Abstract
Nitrendipine is a new dihydropyridine derivative with calcium antagonist properties and a long duration of action. Its effect on calcium ion kinetics appears to be somewhat different than that of conventional calcium antagonists. Nitrendipine has a potent peripheral vasodilatory effect, without having a significant negative inotropic effect. It does not directly affect impulse generation and conduction.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hermsmeyer K, Kuthe C: Calcium antagonists and excitation of the vascular muscle membrane. J Cardiovasc Pharmacol 6:S933, 1984.
Scriabine A, et al: Some recent pharmacological findings with nitrendipine. J Cardiovasc Pharmacol 6:S937, 1984.
Kazda S, et al: Calcium antagonists in hypertensive disease: experimental evidence for a new therapeutic concept. Postgrad Med J [Suppl 2] 59:78, 1983.
Hertle L, et al: Protective effects of the calcium antagonist nisoldipine in ischaemic acute renal failure in the rat. Naunyn Schemiedebergs Arch Pharmacol [Suppl] 324:R46, 1983.
Triggle DJ, Janis RA: The 1, 4-dihydropyridine receptor: a regulator component of the Ca2+ channel. J Cardiovasc Pharmacol 6:S949, 1984.
Kohlhardt M, Happ K: The blockade of Vmax of the atrioventricular action potential produced by the slow channel inhibitors verapamil and nifedipine. Naunyn Schmiedebergs Arch Pharmacol 316:178, 1981.
Kohlhardt M, Fleckenstein A: Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 298:267, 1977.
Kazda S, et al: Mode of antihypertensive action of nitrendipine. J Cardiovasc Pharmacol 6:S956, 1984.
Weber MA, Drayer JIM: The calcium channel blocker nitrendipine in single and multiple-agent antihypertensive regimens: preliminary report of a multicenter study. J Cardiovasc Pharmacol 6.S1077, 1984.
Müller FB, et al: Antihypertensive therapy with the long-acting calcium antagonist nitrendipine. J Cardiovasc Pharmacol 6:S1073, 1984.
Reuter H, et al: Na-Ca exchange and tension development in arterial smooth muscle. Philos Trans R Soc Lond [Biol] 265:87, 1973.
Edmonson RPS, MacGregor GA: Leucocyte cation transport in essential hypertension: its relation to the rennin-angiotensin system. Br Med J 282:1267, 1981.
Bühler FR, et al: Renin profiling to select antihypertensive baseline drugs: renin inhibitors for high and calcium entry blockers for low renin patients. Hypertension [Suppl 2A] 77:36, 1984.
Laragh JH: Lessons from antihypertensive drug trials that employed “stepped care”: the case for rationalized individualized treatment strategies based on renin system patterns. J Cardiovasc Pharmacol 6:S1067, 1984.
Moser M, et al: Nitrendipine in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol 6:S1085, 1984.
Tourkantonis A, et al: Clinical experience with long-term nitrendipine treatment in essential hypertension. J Cardiovasc Pharmacol 6:S1090, 1984.
Lachnit KS, et al: The treatment of hypertension with the calcium-antagonist nitrendipine in old age. An abstract presented at the European Congress on Hypertension, Milan, 1985.
Fritschka E, et al: Crossover comparison of nitrendipine with propranolol in patients with essential hypertension. J Cardiovasc Pharmacol 6:S1100, 1984.
Schoenberger JA, et al: Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension. J Cardiovasc Pharmacol 6.S1105, 1984.
Fagan TC, et al: Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy. J Cardiovasc Pharmacol 6:S1109, 1984.
Höffler D, Stoepel K: Nitrendipine in hypertension that is difficult to control. J Cardiovasc Pharmacol 6:S1060, 1984.
Mannan ME, et al: Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension. J Cardiovasc Pharmacol 6:S1043, 1984.
Levenson J, et al: Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine. J Cardiovasc Pharmacol 6:S1006, 1984.
Sterzel RB, et al: Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension. J Cardiovasc Pharmacol 6:S1024, 1984.
Hall CE, Hungerford S: Effect of nitrendipine on urine volume, osmolality, and electrolyte excretion in normal, adrenal-enucleate, and mononephrectomized rats. J Cardiovasc Pharmacol 6:S1028, 1984.
Thananopavarn C, et al: Renal effects of nitrendipine monotherapy in essential hypertension. J Cardiovasc Pharmacol 6:S1032, 1984.
Olivari MT, el al: Acute hemodynamic effects of nitrendipine in chronic congestive heart failure. J Cardiovasc Pharmacol 6:S1002, 1984.
Andren L, et al: Experience with nitrendipine—a new calcium channel antagonist—in hypertension. J Cardiovasc Pharmacol 4:S387, 1982.
Kann J, et al: Bioequivalence and metabolism of nitrendipine administered orally to healthy volunteers. J Cardiovasc Pharmacol 6:S968, 1984.
Aronoff GR: Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects. J Cardiovasc Pharmacol 6:S974, 1984.
Stoepel K, et al: Safety aspects of long-term nitrendipine therapy. J Cardiovasc Pharmacol 6:S1063, 1984.
Kirch W, et al: Drug interactions with nitrendipine. J Cardiovasc Pharmacol 6:S982, 1984.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1988 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Schneeweiss, A., Schettler, G. (1988). Nitrendipine. In: Cardiovascular Drug Therapy in the Elderly. Developments in Cardiovascular Medicine, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2063-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2063-0_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9225-8
Online ISBN: 978-1-4613-2063-0
eBook Packages: Springer Book Archive